Search Results 971-980 of 16078 for pharmacogenetics
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of this multi-center pilot study is to determine if the drug tocilizumab (Actemra) is effective in the treatment of patients with refractory adult ...
The objectives of this study are to determine whether adequate blood volumes can be obtained with the Tasso+ device for anti-HLA antibody testing, to compare ...
The researchers are trying to identify the specific characteristics (phenotypes) that may be useful to help select the right medication for weight loss.
The purpose of this study is to define the feasibility and effectiveness of a multi-component intervention aimed at decreasing perception of dyspnea in ...
About this study. Mepolizumab is a humanized monoclonal antibody. In conditions where eosinophilia is considered to play an important part in the pathology, ...
The purpose of this study is to determine whether treatment of obstructive sleep apnea (OSA) with positive airway pressure starting shortly after acute ...
Researchers in this brain focus area of the Discovery and Translation Labs at Mayo Clinic focus on translational research related to biomarker and drug ...
About this study. The overarching goal of the Study of a Prospective Research Cohort with Inflammatory Bowel Disease (SPARC IBD) is to create a ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.